Khiron To Conduct Live Virtual Tour Of New Medical Facility On July 21
What do you do when your investors are located thousands of miles away from your new medical facility, but yet still wish to see the progress of your operations? If you’re Khiron Life Sciences (TSXV: KHRN), you host a live interactive tour, lead by your CEO. The company announced this morning that it would be conducted a real-time, interactive tour of the firms recently completed Zerenia medical facility, which is located in Bogota, Colombia.
The virtual tour is being lead by Khiron’s CEO and director Alvaro Torres, who will be live on camera to walk viewers through the virtual tour. Attendees of the tour are invited, and encouraged, to ask real time questions of the company while they go on the virtual tour of the new medical facility. Attendees are set to learn about Khiron’s clinical model, meet members of the medical team, and ask questions about Zerenia’s operations amid the global pandemic.
The live virtual tour is said to be the first in a series of interactive events currently planned by Khiron as a means of keeping an open dialogue with investors. An archived recording will be available after the event for those that are unable to attend for a live viewing.
The live virtual tour is scheduled to take place on Tuesday, July 21, 2020 at 9:00 AM eastern time. Attendees can RSVP to the event by going here.
Khiron Life Sciences last traded at $0.50 on the TSX Venture.
FULL DISCLOSURE: Khiron Life Sciences is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Khiron Life Sciences on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.
